Apolipoprotein E Effectively Inhibits Lipoprotein Lipase-mediated Lipolysis of Chylomicron-like Triglyceride-rich Lipid Emulsions in Vitro and in Vivo*

Apolipoprotein E (apoE) is an important determinant for the liver uptake of triglyceride-rich lipoproteins and emulsions by the remnant receptor. In the current study, we assessed an additional role of apoE as modulator of the metabolism of triglyceride-rich lipoproteins in vitro and in vivo. Glycerol tri[3H]oleate [14C]cholesteryl oleate double-labeled triglyceride-rich emulsions were injected into fasted rats. The serum half-life of glycerol tri[3H]oleate was 3-fold faster (5.4 min) than that of [14C]cholesteryl oleate (16.7 min), confirming lipoprotein lipase (LPL)-mediated processing. To establish a specific effect of apoE on emulsion lipolysis rather than liver uptake, rats were functionally hepatectomized, and hypo(apo)lipoproteinemia was induced by 17α-ethinyl estradiol treatment. An apoE concentration-dependent inhibition of emulsion-triglyceride hydrolysis was observed, reaching a 14.8-fold increased half-life of glycerol tri[3H]oleate as compared with that in the absence of exogenous apoE. The mechanism and specificity of the effect of apoE on emulsion lipolysis by purified LPL was assessed in vitro. Addition of apoE to glycerol tri[3H]oleate-labeled emulsions led to a concentration-dependent inhibition of [3H]oleate release (9.5% residual LPL activity at 60 μg/ml apoE), while apoA-I was ineffective. The inhibitory effect of apoE was not abolished by reductive methylation of lysine residues, whereas selective modification of arginine residues by 1,2-cyclohexadione completely cancelled the inhibitory effect of apoE. It is concluded that apoE can specifically inhibit the LPL-mediated hydrolysis of emulsion triglycerides both in vitro and in vivo, and that arginine residues in apoE are essential for this effect. We suggest that in addition to its role in receptor recognition, apoE also modulates the LPL-mediated processing of triglyceride-rich lipoproteins.

[1]  R. Hegele,et al.  Apolipoprotein B and E basic amino acid clusters influence low-density lipoprotein association with lipoprotein lipase anchored to the subendothelial matrix. , 1995, Arteriosclerosis, thrombosis, and vascular biology.

[2]  J. K. Kruijt,et al.  Selective liver targeting of antivirals by recombinant chylomicrons — a new therapeutic approach to hepatitis B , 1995, Nature Medicine.

[3]  B. Wieringa,et al.  Diet-induced hypercholesterolemia and atherosclerosis in heterozygous apolipoprotein E-deficient mice. , 1994, Atherosclerosis.

[4]  R. Hegele,et al.  Kinetics of lipolysis of very low density lipoproteins by lipoprotein lipase. Importance of particle number and noncompetitive inhibition by particles with low triglyceride content. , 1994, The Journal of biological chemistry.

[5]  J. Lalouel,et al.  Cellular catabolism of normal very low density lipoproteins via the low density lipoprotein receptor-related protein/alpha 2-macroglobulin receptor is induced by the C-terminal domain of lipoprotein lipase. , 1994, The Journal of biological chemistry.

[6]  R. Davis,et al.  Lipoprotein lipase domain function. , 1994, The Journal of biological chemistry.

[7]  J. Lalouel,et al.  The carboxyl-terminal domain of lipoprotein lipase binds to the low density lipoprotein receptor-related protein/alpha 2-macroglobulin receptor (LRP) and mediates binding of normal very low density lipoproteins to LRP. , 1994, The Journal of biological chemistry.

[8]  J. Lalouel,et al.  Lipoprotein lipase. Molecular model based on the pancreatic lipase x-ray structure: consequences for heparin binding and catalysis. , 1994, The Journal of biological chemistry.

[9]  M. Stins,et al.  Specificity of lipoprotein lipase binding to endothelial cells. , 1993, Journal of lipid research.

[10]  S. Moestrup,et al.  The alpha 2-macroglobulin receptor/low density lipoprotein receptor-related protein binds lipoprotein lipase and beta-migrating very low density lipoprotein associated with the lipase. , 1993, The Journal of biological chemistry.

[11]  C. Bisgaier,et al.  Apolipoprotein E modulates low density lipoprotein retention by lipoprotein lipase anchored to the subendothelial matrix. , 1993, The Journal of biological chemistry.

[12]  M. Waknitz,et al.  Lipoprotein lipase induces catabolism of normal triglyceride-rich lipoproteins via the low density lipoprotein receptor-related protein/alpha 2-macroglobulin receptor in vitro. A process facilitated by cell-surface proteoglycans. , 1993, The Journal of biological chemistry.

[13]  D. Gómez-Coronado,et al.  Different hydrolytic efficiencies of adipose tissue lipoprotein lipase on very-low-density lipoprotein subfractions separated by heparin-Sepharose chromatography. , 1993, Biochimica et biophysica acta.

[14]  T. Olivecrona,et al.  New aspects on heparin and lipoprotein metabolism. , 1993, Haemostasis.

[15]  A. Jonas,et al.  The number of amphipathic alpha-helical segments of apolipoproteins A-I, E, and A-IV determines the size and functional properties of their reconstituted lipoprotein particles. , 1993, The Journal of biological chemistry.

[16]  M. Brown,et al.  Low density lipoprotein receptor-related protein and gp330 bind similar ligands, including plasminogen activator-inhibitor complexes and lactoferrin, an inhibitor of chylomicron remnant clearance. , 1992, The Journal of biological chemistry.

[17]  D. Sparks,et al.  The conformation of apolipoprotein A-I in discoidal and spherical recombinant high density lipoprotein particles. 13C NMR studies of lysine ionization behavior. , 1992, The Journal of biological chemistry.

[18]  Henry N. Ginsberg,et al.  Mechanism of hypertriglyceridemia in human apolipoprotein (apo) CIII transgenic mice. Diminished very low density lipoprotein fractional catabolic rate associated with increased apo CIII and reduced apo E on the particles. , 1992, The Journal of clinical investigation.

[19]  S. Eisenberg,et al.  Triacylglycerol and phospholipid hydrolysis in human plasma lipoproteins: role of lipoprotein and hepatic lipase. , 1992, Biochemistry.

[20]  M. Klein,et al.  Identification of a heparin-releasable lipoprotein lipase binding protein from endothelial cells. , 1992, The Journal of biological chemistry.

[21]  T. Olivecrona,et al.  Interaction of size-fractionated heparins with lipoprotein lipase and hepatic lipase in the rat. , 1992, The Biochemical journal.

[22]  J. Fruchart,et al.  Inhibition of lipoprotein lipase activity by synthetic peptides of apolipoprotein C-III. , 1992, Journal of lipid research.

[23]  R. Frants,et al.  Heparan sulphate proteoglycans are involved in the lipoprotein lipase-mediated enhancement of the cellular binding of very low density and low density lipoproteins. , 1992, Biochemical and biophysical research communications.

[24]  T. V. van Berkel,et al.  Lactoferrin uptake by the rat liver. Characterization of the recognition site and effect of selective modification of arginine residues. , 1992, The Journal of biological chemistry.

[25]  T. V. van Berkel,et al.  Characterization of the chylomicron-remnant-recognition sites on parenchymal and Kupffer cells of rat liver. Selective inhibition of parenchymal cell recognition by lactoferrin. , 1992, European journal of biochemistry.

[26]  M. Klein,et al.  Lipoprotein lipase increases low density lipoprotein retention by subendothelial cell matrix. , 1992, The Journal of clinical investigation.

[27]  T. V. van Berkel,et al.  Recognition of chylomicron remnants and beta-migrating very-low-density lipoproteins by the remnant receptor of parenchymal liver cells is distinct from the liver alpha 2-macroglobulin-recognition site. , 1991, The Biochemical journal.

[28]  G. Bengtsson-Olivecrona,et al.  Lipoprotein lipase enhances the binding of chylomicrons to low density lipoprotein receptor-related protein. , 1991, Proceedings of the National Academy of Sciences of the United States of America.

[29]  M. Klein,et al.  Identification and characterization of the endothelial cell surface lipoprotein lipase receptor. , 1991, The Journal of biological chemistry.

[30]  T. Olivecrona,et al.  Low-Mr heparin is as potent as conventional heparin in releasing lipoprotein lipase, but is less effective in preventing hepatic clearance of the enzyme. , 1991, The Biochemical journal.

[31]  I. Goldberg,et al.  Interaction of lipoprotein lipase with glycosaminoglycans and apolipoprotein C-II: effects of free-fatty-acids. , 1990, Biochimica et biophysica acta.

[32]  I. Goldberg,et al.  Lipoprotein ApoC-II activation of lipoprotein lipase. Modulation by apolipoprotein A-IV. , 1990, The Journal of biological chemistry.

[33]  B. Bihain,et al.  Fatty acid control of lipoprotein lipase: a link between energy metabolism and lipid transport. , 1990, Proceedings of the National Academy of Sciences of the United States of America.

[34]  T. V. van Berkel,et al.  Lactosylated low density lipoprotein: a potential carrier for the site-specific delivery of drugs to Kupffer cells. , 1989, Molecular pharmacology.

[35]  C. Fielding,et al.  Apolipoprotein E mediates binding of normal very low density lipoprotein to heparin but is not required for high affinity receptor binding. , 1989, The Journal of biological chemistry.

[36]  W. Mcconathy,et al.  Inhibition of lipoprotein lipase by the receptor‐binding domain of apolipoprotein E , 1989, FEBS letters.

[37]  R. Mahley,et al.  Apolipoprotein E: cholesterol transport protein with expanding role in cell biology. , 1988, Science.

[38]  C. Luo,et al.  The apolipoprotein multigene family: biosynthesis, structure, structure-function relationships, and evolution. , 1988, Journal of lipid research.

[39]  C. Fielding,et al.  A change in apolipoprotein B expression is required for the binding of apolipoprotein E to very low density lipoprotein. , 1988, The Journal of biological chemistry.

[40]  M. Boguski,et al.  On computer-assisted analysis of biological sequences: proline punctuation, consensus sequences, and apolipoprotein repeats. , 1986, Journal of lipid research.

[41]  H. Greten,et al.  Influence of lysophosphatidylcholine on the C-apolipoprotein content of rat and human triglyceride-rich lipoproteins during triglyceride hydrolysis. , 1986, Journal of Clinical Investigation.

[42]  S. Yokoyama,et al.  Comparison of apolipoprotein C-II-deficient triacylglycerol-rich lipoproteins and trioleoylglycerol/phosphatidylcholine-stabilized particles as substrates for lipoprotein lipase. , 1986, Biochimica et biophysica acta.

[43]  J. Borensztajn,et al.  Heparin-binding apoproteins. Effects on lipoprotein lipase and hepatic uptake of remnants. , 1986, The Biochemical journal.

[44]  S. Yokoyama,et al.  Behavior of human apolipoprotein E in aqueous solutions and at interfaces. , 1985, The Journal of biological chemistry.

[45]  T. Olivecrona,et al.  Distribution of lipoprotein lipase and hepatic lipase between plasma and tissues: effect of hypertriglyceridemia. , 1985, Biochimica et biophysica acta.

[46]  J. Taylor,et al.  Human apolipoprotein E expression in Escherichia coli: structural and functional identity of the bacterially produced protein with plasma apolipoprotein E. , 1985, Proceedings of the National Academy of Sciences of the United States of America.

[47]  J. Hartsuck,et al.  Kinetics of acylglycerol hydrolysis by human milk lipoprotein lipase. , 1985, Biochimica et biophysica acta.

[48]  J. C. Osborne,et al.  Studies on inactivation of lipoprotein lipase: role of the dimer to monomer dissociation. , 1985, Biochemistry.

[49]  J. Nordenström,et al.  Lipolytic and anticoagulant activities of a low molecular weight fragment of heparin , 1985, European journal of clinical investigation.

[50]  R. Maranhão,et al.  Metabolism of protein-free lipid emulsion models of chylomicrons in rats. , 1985, Biochimica et biophysica acta.

[51]  S. Quarfordt,et al.  Apolipoprotein effects on the lipolysis of perfused triglyceride by heparin-immobilized milk lipase. , 1985, The Journal of biological chemistry.

[52]  R. Havel.  The formation of LDL: mechanisms and regulation. , 1984, Journal of lipid research.

[53]  H. Brewer,et al.  Amino acid sequence of human plasma apolipoprotein C-II from normal and hyperlipoproteinemic subjects. , 1984, The Journal of biological chemistry.

[54]  R. Burrier,et al.  Hydrolysis of triolein in phospholipid vesicles and microemulsions by a purified rat liver acid lipase. , 1983, The Journal of biological chemistry.

[55]  M. Shinomiya,et al.  Lipoprotein lipase-catalyzed hydrolysis of phosphatidylcholine of guinea pig very low density lipoproteins and discoidal complexes of phospholipid and apolipoprotein: effect of apolipoprotein C-II on the catalytic mechanism. , 1983, Journal of lipid research.

[56]  Y. Marcel,et al.  Cholesteryl ester and apolipoprotein E transfer between human high density lipoproteins and chylomicrons. , 1983, Biochimica et biophysica acta.

[57]  H. Eder,et al.  Effects of 17 alpha-ethinyl estradiol on the serum lipoproteins of cholesterol-fed diabetic rats. , 1980, Journal of Biological Chemistry.

[58]  R J Havel,et al.  Regulation of the hepatic uptake of triglyceride-rich lipoproteins in the rat. Opposing effects of homologous apolipoprotein E and individual C apoproteins. , 1980, The Journal of biological chemistry.

[59]  H. Brewer,et al.  Activation of human post heparin lipoprotein lipase by apolipoprotein H (beta 2-glycoprotein I). , 1980, Biochemical and biophysical research communications.

[60]  T. Murase,et al.  Modulation, by apolipoprotein E, of lipoprotein lipase activity. , 1980, Biochemical and biophysical research communications.

[61]  R. Mahley,et al.  Subfractionation of human high density lipoproteins by heparin-Sepharose affinity chromatography. , 1980, Journal of lipid research.

[62]  Y. Chao,et al.  Hepatic catabolism of rat and human lipoproteins in rats treated with 17 alpha-ethinyl estradiol. , 1979, The Journal of biological chemistry.

[63]  R. Mahley,et al.  Role of lysine residues of plasma lipoproteins in high affinity binding to cell surface receptors on human fibroblasts. , 1978, The Journal of biological chemistry.

[64]  P. Groot,et al.  Triglyceridase and phospholipase A1 activities of rat-heart lipoprotein lipase. Influence of apolipoproteins C-II and C-III. , 1978, Biochimica et biophysica acta.

[65]  F. M. Hooft,et al.  Discrepancies in the catabolic pathways of rat and human low density lipoproteins as revealed by partial hepatectomy in the rat , 1978 .

[66]  O. Faergeman,et al.  Characterization of remnants produced during the metabolism of triglyceride-rich lipoproteins of blood plasma and intestinal lymph in the rat. , 1975, The Journal of clinical investigation.

[67]  C. E. West,et al.  Separation of plasma lipoproteins by density-gradient ultracentrifugation. , 1975, Analytical biochemistry.

[68]  E. L. Smith,et al.  Reversible modification of arginine residues. Application to sequence studies by restriction of tryptic hydrolysis to lysine residues. , 1975, The Journal of biological chemistry.

[69]  J. Larosa,et al.  A specific apoprotein activator for lipoprotein lipase. , 1970, Biochemical and biophysical research communications.

[70]  T. Redgrave.  Formation of cholesteryl ester-rich particulate lipid during metabolism of chylomicrons. , 1970, The Journal of clinical investigation.

[71]  P. Belfrage,et al.  Simple liquid-liquid partition system for isolation of labeled oleic acid from mixtures with glycerides. , 1969, Journal of lipid research.

[72]  A. Habeeb,et al.  Determination of free amino groups in proteins by trinitrobenzenesulfonic acid. , 1966, Analytical biochemistry.

[73]  A. Mcfarlane,et al.  Efficient Trace-labelling of Proteins with Iodine , 1958, Nature.

[74]  K. Weisgraber.  Apolipoprotein E: structure-function relationships. , 1994, Advances in protein chemistry.

[75]  A Cryer,et al.  Tissue lipoprotein lipase activity and its action in lipoprotein metabolism. , 1981, The International journal of biochemistry.

[76]  R. Havel,et al.  Interchange of apolipoproteins between chylomicrons and high density lipoproteins during alimentary lipemia in man. , 1973, The Journal of clinical investigation.